Halozyme appoints CMO
This article was originally published in Scrip
San Diego-based Halozyme Therapeutics has named Dr Athena Countouriotis chief medical officer. She will be responsible for directing Halozyme's research, clinical development and regulatory activities. Most recently, Dr Countouriotis was CMO at Ambit Biosciences (acquired by Daiichi Sankyo in November 2014).
You may also be interested in...
A selection of features you might have missed from the first six months of 2020, covering key topics from COVID-19 strategies in medtech to an analysis of pipeline focus areas across the pharma sector. Click on each section to get the full story behind the data.
The two-part vaccine becomes the second against Ebola to get approval. Janssen is now collaborating with the World Health Organization on vaccine pre-qualification to get it to people in need.
Johan Van Hoof, global head of vaccines at Janssen, talks to In Vivo about the company’s platform, how it is approaching COVID-19 research and the impact of today’s global pandemic on the future of vaccine R&D.